Advancing Metabolic Markers in Psychiatry: Investigating the Effects of TAAR1 Agonists on Metabolic Control in Schizophrenia Patients with Co-Morbid Metabolic Syndrome & Pre-Diabetes
Time: 11:15 am
day: Day One Track B AM
Details:
- Employing metabolic biomarkers to study gastric emptying, insulin-glucose homeostasis, and liver fat
- TAAR1 agonism and potential utility of metabolic biomarkers
- Peripheral metabolic markers in combination with CNS markers: implications for schizophrenia drug development
